Company context

Roche Holding Ltd

SIX:RO

Pharmaceuticals: Major · benchmarked against Pharmaceuticals: Major inside the VXUS constituent company universe.

Active tabPeers

Current readMixed

Last close337.40

1M return-0.24%

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Relative comparables

Peers

Source and lookbackPeer fundamentals and stored return summaries5304 stored daily bars; peer return rows use each peer's stored price summary where available.

Sample and caveat12 closest comparables from industry, sector, and market peer pools.Use this tab for its stated job; heavier model packets stay on their own tabs.

Peer return matrix

Cumulative returns across peer horizons

Stored daily closes, when available

SIX:RO 1W +0.18%, 1M -0.24%, 3M +2.74%, 6M -7.05%, 1Y +29.57%, 3Y +18.55%; SIX:ROP 1W -0.57%, 1M -0.63%, 3M +3.22%, 6M -7.49%, 1Y +32.62%, 3Y +21.84%; SIX:NOVN 1W +1.85%, 1M +0.35%, 3M +8.32%, 6M +4.44%, 1Y +34.92%, 3Y +38.32%; LSE:AZN 1W -1.08%, 1M -11.40%, 3M -9.25%, 6M -11.80%, 1Y +12.68%, 3Y +14.86%; LSE:GSK 1W -3.22%, 1M -4.54%, 3M +0.37%, 6M -12.68%, 1Y +34.78%, 3Y +37.45%; EURONEXT:SAN 1W -0.25%, 1M +3.01%, 3M +4.79%, 6M -7.04%, 1Y -8.13%, 3Y -22.45%; OMXCOP:NOVO_B 1W -3.50%, 1M +0.92%, 3M +11.63%, 6M +15.46%, 1Y +11.93%, 3Y -41.09%; EURONEXT:UCB 1W +1.01%, 1M -5.62%, 3M +0.42%, 6M -9.40%, 1Y +26.17%, 3Y +192.02%; LSE:HLN 1W +3.18%, 1M +11.83%, 3M +4.10%, 6M +2.58%, 1Y +4.07%, 3Y +10.49%; XETR:MRK 1W -4.24%, 1M -7.49%, 3M +9.04%, 6M +5.22%, 1Y +22.31%, 3Y -17.51%; TSE:4503 1W +0.91%, 1M -1.83%, 3M -8.45%, 6M -10.47%, 1Y +45.67%, 3Y +5.17%

Company1W1M3M

6M

1Y

3Y

SIX:RO+0.18%-0.24%+2.74%-7.05%+29.57%+18.55%

SIX:ROP-0.57%-0.63%+3.22%-7.49%+32.62%+21.84%

SIX:NOVN+1.85%+0.35%+8.32%+4.44%+34.92%+38.32%

LSE:AZN-1.08%-11.40%-9.25%-11.80%+12.68%+14.86%

LSE:GSK-3.22%-4.54%+0.37%-12.68%+34.78%+37.45%

EURONEXT:SAN-0.25%+3.01%+4.79%-7.04%-8.13%-22.45%

OMXCOP:NOVO_B-3.50%+0.92%+11.63%+15.46%+11.93%-41.09%

EURONEXT:UCB+1.01%-5.62%+0.42%-9.40%+26.17%+192.02%

LSE:HLN+3.18%+11.83%+4.10%+2.58%+4.07%+10.49%

XETR:MRK-4.24%-7.49%+9.04%+5.22%+22.31%-17.51%

TSE:4503+0.91%-1.83%-8.45%-10.47%+45.67%+5.17%

Peer scorecard analytics

Different ways to compare this peer set

11 companies including target

Return leadership

TSE:4503+45.67% 1Y · +5.17% 3Y

SIX:NOVN+34.92% 1Y · +38.32% 3Y

LSE:GSK+34.78% 1Y · +37.45% 3Y

SIX:ROP+32.62% 1Y · +21.84% 3Y

Risk and quality spread

OMXCOP:NOVO_BGM +81.85% · ROE +71.40%

SIX:ROGM +73.23% · ROE +39.29%

SIX:ROPGM +73.23% · ROE +39.29%

LSE:GSKGM +72.80% · ROE +36.42%

Valuation screen

OMXCOP:NOVO_BP/E 11.82 · FCF yield +2.75%

LSE:GSKP/E 13.30 · FCF yield +7.62%

TSE:4503P/E 13.54 · FCF yield +13.44%

EURONEXT:SANP/E 18.04 · FCF yield +9.93%

Valuation versus growth

P/E against 1Y return

SIX:RO P/E 21.04 1Y +29.57%, SIX:ROP P/E 20.57 1Y +32.62%, SIX:NOVN P/E 22.36 1Y +34.92%, LSE:AZN P/E 25.17 1Y +12.68%, LSE:GSK P/E 13.30 1Y +34.78%, EURONEXT:SAN P/E 18.04 1Y -8.13%, OMXCOP:NOVO_B P/E 11.82 1Y +11.93%, EURONEXT:UCB P/E 29.94 1Y +26.17%, LSE:HLN P/E 20.02 1Y +4.07%, XETR:MRK P/E 22.67 1Y +22.31%, TSE:4503 P/E 13.54 1Y +45.67%

Peer heatmap

Where this company wins and lags

12 stored peers

CompanyP/E TTMPrice / SalesFCF yieldGross marginReturn on equityDebt / Equity

SIX:RORoche Holding Ltd

21.0462nd pctile4.3957th pctile+5.42%67th pctile+73.23%69th pctile+39.29%93rd pctile0.9817th pctile

SIX:ROPRoche Holding Ltd

20.5757th pctile4.3357th pctile+5.40%43rd pctile+73.23%50th pctile+39.29%79th pctile0.9836th pctile

SIX:NOVNNovartis AG

22.3629th pctile5.4014th pctile+6.32%71st pctile+74.60%86th pctile+33.54%43rd pctile1.220th pctile

LSE:AZNAstraZeneca PLC

25.1714th pctile4.2971st pctile+4.36%29th pctile+74.31%71st pctile+22.89%29th pctile0.7271st pctile

LSE:GSKGSK plc

13.3086th pctile2.3486th pctile+7.62%86th pctile+72.80%29th pctile+36.42%57th pctile1.0714th pctile

EURONEXT:SANSanofi SA

18.0471st pctile2.13100th pctile+9.93%100th pctile+65.92%0th pctile+6.63%0th pctile0.2886th pctile

OMXCOP:NOVO_BNovo Nordisk A/S Class B

11.82100th pctile4.4529th pctile+2.75%0th pctile+81.85%100th pctile+71.40%100th pctile0.7257th pctile

EURONEXT:UCBUCB S.A.

29.940th pctile5.970th pctile+4.26%14th pctile+71.14%14th pctile+14.91%14th pctile0.21100th pctile

Color ranks each metric in the favorable direction, so lower leverage and cheaper multiples can still score green.